Fomivirsen (DepoTech/Isis)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameFomivirsen (DepoTech/Isis)
Drug Alias Namefomivirsenfomivirsen, sustained-release formulation (DepoTech/Isis)antisense oligonucleotides (DepoTech/Isis)DepoAntisense
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionVirus replication inhibitorsAntisense oligonucleotide inhibitors
TargetsUpdating
Therapy Area/IndicationsCMV retinitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPacira Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPacira Biosciences IncIonis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCMV retinitis

Other Information

ATC CodeN/A
Related LinksN/A